We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aggrenox Pay-for-Delay Lawsuit Against Boehringer, Teva Survives Dismissal Bid
Aggrenox Pay-for-Delay Lawsuit Against Boehringer, Teva Survives Dismissal Bid
A federal judge has given the go-ahead to a class action lawsuit alleging Boehringer Ingelheim and Teva conspired to put off generic competition to the antistroke drug Aggrenox.